Skip to main content
. 2022 Dec 28;24(1):499. doi: 10.3390/ijms24010499

Table 1.

Participant demographics.

Criteria Healthy Donors (n = 8) IPF Patients (n = 16)
Age (mean years ± SD) 56 ± 18 64 ± 8
Sex
Male (%) 75 81
Female (%) 25 19
Smoking status
Ever smoker (%) 37.5 56
Never smoker (%) 0 25
Unknown (%) 62.5 19
Years with IPF disease (mean ± SD) n/a * 5.1 ± 3.1
IPF treatment before transplantation
Nintedanib (%) 0 0
Pirfenidone (%) 0 12.5
FVC (% mean ± SD) n/a * 41 ± 12

* n/a: not applicable or not available.